Circulating DNA: Diagnostic tool and predictive marker for overall survival of NSCLC patients

54Citations
Citations of this article
60Readers
Mendeley users who have this article in their library.

Abstract

Purpose: The purpose of our study was to determine whether the amounts of circulating DNA (cDNA) could discriminate between NSCLC patients and healthy individuals and assess its value as a prognostic marker of this disease. Methods: We conducted a study of 309 individuals and the cDNA levels were assessed through real-time PCR methodology. Results: We found increased cDNA levels in NSCLC patients compared to control individuals. We also found a decreased overall survival time in patients presenting high cDNA levels, when compared to lower cDNA concentrations. Conclusions: Quantification of cDNA may be a good tool for NSCLC detection with potential for clinical applicability. © 2012 Catarino et al.

Cite

CITATION STYLE

APA

Catarino, R., Coelho, A., Araújo, A., Gomes, M., Nogueira, A., Lopes, C., & Medeiros, R. (2012). Circulating DNA: Diagnostic tool and predictive marker for overall survival of NSCLC patients. PLoS ONE, 7(6). https://doi.org/10.1371/journal.pone.0038559

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free